日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-world cardiac events and outcomes in cBTKi-treated chronic lymphocytic leukemia patients

cBTKi治疗的慢性淋巴细胞白血病患者的真实世界心脏事件和预后

Dingli, David; De Nigris, Enrico; Leng, Siyang; Farooqui, Mohammed Z H; Yapici, Halit O; Weimer, Ian; Jiao, Weiqi; Hyatt, Hayden; Zhang, Xuan; Lodaya, Kunal; Obeng-Kusi, Mavis

Utilizing Causal Network Markers to Identify Tipping Points ahead of Critical Transition

利用因果网络标记识别关键转型前的转折点

Bian, Shirui; Wang, Zezhou; Leng, Siyang; Lin, Wei; Shi, Jifan

Healthcare Resource Utilization and Costs in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia Treated With Covalent Bruton's Tyrosine Kinase Inhibitors: Real-World Impact of Cardiovascular Adverse Events

使用共价布鲁顿酪氨酸激酶抑制剂治疗慢性淋巴细胞白血病或小淋巴细胞白血病患者的医疗资源利用和成本:心血管不良事件的真实世界影响

Obeng-Kusi, Mavis; De Nigris, Enrico; Leng, Siyang; Farooqui, Mohammed Z H; Yapici, Halit O; Weimer, Ian; Jiao, Weiqi; Hyatt, Hayden W; Zhang, Xuan; Lodaya, Kunal; Dingli, David

Real-world characteristics, treatment patterns, and outcomes of patients with 2 or more LOTs for CLL/SLL in the United States

美国接受 2 种或以上 CLL/SLL 治疗方案的患者的真实世界特征、治疗模式和结果

Davids, Matthew S; Ambrose, Jacob; de Nigris, Enrico; Prescott, Jennifer; Leng, Siyang; Farooqui, Mohammed Z H; Gandra, Shravanthi R; Zettler, Christina M; Fernandes, Laura L; Wang, Ching Kun; Shadman, Mazyar

Real-world analysis of adverse event rates after initiation of ibrutinib among Medicare beneficiaries with chronic lymphocytic leukemia

对接受伊布替尼治疗的慢性淋巴细胞白血病Medicare受益者进行真实世界不良事件发生率分析

Huntington, Scott F; de Nigris, Enrico; Puckett, Justin T; Kamal-Bahl, Sachin; Farooqui, Mohammed; Ryland, Katherine; Sarpong, Eric M; Leng, Siyang; Yang, Xiaoqin; Doshi, Jalpa A

Distributed Consensus Algorithms in Sensor Networks with Higher-Order Topology.

具有高阶拓扑结构的传感器网络中的分布式共识算法

Chen Qianyi, Shi Wenyuan, Sui Dongyan, Leng Siyang

Phase I/II study of carfilzomib, bendamustine, and dexamethasone (CBD) in patients with newly diagnosed multiple myeloma

卡非佐米、苯达莫司汀和地塞米松(CBD)治疗新诊断多发性骨髓瘤患者的I/II期研究

Leng, Siyang; Bhutani, Divaya; Raza, Shahzad; Assal, Amer; Pan, Samuel; Hu, Jianhua; Wei, Alexander; Mapara, Markus; Lentzsch, Suzanne

Detection for disease tipping points by landscape dynamic network biomarkers

利用景观动态网络生物标志物检测疾病临界点

Liu, Xiaoping; Chang, Xiao; Leng, Siyang; Tang, Hui; Aihara, Kazuyuki; Chen, Luonan

How I treat a refractory myeloma patient who is not eligible for a clinical trial

如何治疗不符合临床试验条件的难治性多发性骨髓瘤患者

Leng, Siyang; Bhutani, Divaya; Lentzsch, Suzanne

Management and outcomes of proteasome inhibitor associated chalazia and blepharitis: a case series

蛋白酶体抑制剂相关性霰粒肿和睑缘炎的治疗及预后:病例系列研究

Sklar, Bonnie A; Gervasio, Kalla A; Leng, Siyang; Ghosh, Arnab; Chari, Ajai; Wu, Albert Y